These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 36012417)
1. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review. Koguchi D; Matsumoto K; Shiba I; Harano T; Okuda S; Mori K; Hirano S; Kitajima K; Ikeda M; Iwamura M Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012417 [TBL] [Abstract][Full Text] [Related]
2. Liquid Biopsy in Bladder Cancer. Cui Y; Cao M Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114 [TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring. Lodewijk I; Dueñas M; Rubio C; Munera-Maravilla E; Segovia C; Bernardini A; Teijeira A; Paramio JM; Suárez-Cabrera C Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149597 [TBL] [Abstract][Full Text] [Related]
4. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging. Shkolyar E; Zhao Q; Mach KE; Teslovich NC; Lee TJ; Cox S; Skinner EC; Lu Y; Liao JC Urol Oncol; 2021 Aug; 39(8):497.e9-497.e15. PubMed ID: 33766467 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer. Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938 [TBL] [Abstract][Full Text] [Related]
6. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer. Huttanus HM; Vu T; Guruli G; Tracey A; Carswell W; Said N; Du P; Parkinson BG; Orlando G; Robertson JL; Senger RS PLoS One; 2020; 15(8):e0237070. PubMed ID: 32822394 [TBL] [Abstract][Full Text] [Related]
7. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775 [No Abstract] [Full Text] [Related]
8. Quantification of MicroRNAs in Urine-Derived Specimens. Fuessel S; Lohse-Fischer A; Vu Van D; Salomo K; Erdmann K; Wirth MP Methods Mol Biol; 2018; 1655():201-226. PubMed ID: 28889388 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA. Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035 [TBL] [Abstract][Full Text] [Related]
11. New method to preserve the original proportion and integrity of urinary cell-free DNA. Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467 [TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA panels for specific and early detection in bladder cancer. Usuba W; Urabe F; Yamamoto Y; Matsuzaki J; Sasaki H; Ichikawa M; Takizawa S; Aoki Y; Niida S; Kato K; Egawa S; Chikaraishi T; Fujimoto H; Ochiya T Cancer Sci; 2019 Jan; 110(1):408-419. PubMed ID: 30382619 [TBL] [Abstract][Full Text] [Related]
13. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker. Piao XM; Cha EJ; Yun SJ; Kim WJ Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer. Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887 [TBL] [Abstract][Full Text] [Related]
15. The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review. Khetrapal P; Lee MWL; Tan WS; Dong L; de Winter P; Feber A; Kelly JD Cancer Treat Rev; 2018 May; 66():56-63. PubMed ID: 29684744 [TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer. Chen H; Xu C; Fang Z; Mao S Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118 [TBL] [Abstract][Full Text] [Related]
17. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. Chen X; Zhang J; Ruan W; Huang M; Wang C; Wang H; Jiang Z; Wang S; Liu Z; Liu C; Tan W; Yang J; Chen J; Chen Z; Li X; Zhang X; Xu P; Chen L; Xie R; Zhou Q; Xu S; Irwin DL; Fan JB; Huang J; Lin T J Clin Invest; 2020 Dec; 130(12):6278-6289. PubMed ID: 32817589 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study. Anastasi E; Maggi M; Tartaglione S; Angeloni A; Gennarini G; Leoncini PP; Sperduti I; Di Lascio G; De Stefano V; Di Pierro GB; Del Giudice F; Busetto GM; De Berardinis E; Sciarra A Diagn Cytopathol; 2020 Nov; 48(11):1034-1040. PubMed ID: 32562513 [TBL] [Abstract][Full Text] [Related]
19. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers. Lin SY; Linehan JA; Wilson TG; Hoon DSB Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876 [TBL] [Abstract][Full Text] [Related]
20. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer. Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]